DermTech, Inc. Common Stock
DMTK
DMTK was delisted on the 26th of June, 2024.
24 hedge funds and large institutions have $133M invested in DermTech, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 4 closing their positions.
600% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 1
3% more capital invested
Capital invested by funds: $128M → $133M (+$4.04M)
0% more funds holding
Funds holding: 24 → 24 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$5.08M |
| 2 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$2.26M |
| 3 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$1.94M |
| 4 |
MSU
Mizuho Securities USA
New York
|
+$1.89M |
| 5 |
AGM
Alpine Global Management
New York
|
+$1.25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
-$4.51M |
| 2 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
-$1.83M |
| 3 |
LIM
Longfellow Investment Management
Boston,
Massachusetts
|
-$1.68M |
| 4 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$1.32M |
| 5 |
GCL
Glazer Capital LLC
New York
|
-$422K |
DMTK Hedge Fund Activity: Q4 2018 in Review
24 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q4 2018, worth a combined $133M — up 3.1% from $128M a quarter earlier.
Fund positioning in DMTK was balanced in Q4 2018: 4 funds opened new positions, 4 closed out, 7 added to existing stakes and 1 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $5.08M. The largest seller was Boothbay Fund Management, exiting entirely with an estimated $4.51M sold.
- 24 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q4 2018, unchanged from Q3 2018.
- Funds reported $133M of DermTech, Inc. Common Stock stock for Q4 2018, up 3.1% quarter-over-quarter.
- 4 funds opened new DermTech, Inc. Common Stock positions in Q4 2018 and 4 closed out, a net change of 0 holders.
- The largest DermTech, Inc. Common Stock buyer in Q4 2018 was Millennium Management, an estimated $5.08M added.
- The largest DermTech, Inc. Common Stock seller in Q4 2018 was Boothbay Fund Management, an estimated $4.51M sold.
Based on aggregated 13F filings for Q4 2018.